TFG-MET fusion in an infantile spindle cell sarcoma with neural features-Reference-Cited by-同舟云学术

TFG-MET fusion in an infantile spindle cell sarcoma with neural features

Published:2017-06-27 Issue:9 Volume:56 Page:663-667
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Flucke Uta¹^ORCID,van Noesel Max M.²,Wijnen Marc²,Zhang Lei³,Chen Chun-Liang³,Sung Yun-Shao³,Antonescu Cristina R.³^ORCID

Affiliation:

1. Department of Pathology; Radboud University Medical Centre; Nijmegen The Netherlands

2. Princess Máxima Center for Pediatric Oncology; Utrecht The Netherlands

3. Department of Pathology; Memorial Sloan Kettering Cancer Center; New York New York

Funder

Kristen Ann Carr Foundation

Cycle for Survival

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference16 articles.

1. Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors;Bourgeois;Am J Surg Pathol.,2000

2. A molecular study of pediatric spindle and sclerosing rhabdomyosarcoma: identification of novel and recurrent VGLL2-related fusions in infantile cases;Alaggio;Am J Surg Pathol.,2016

3. Myofibromas with atypical features: expanding the morphologic spectrum of a benign entity;Linos;Am J Surg Pathol.,2014

4. Recurrent SRF-RELA fusions define a novel subset of cellular variants in the myofibroma/myopericytoma spectrum: a potential diagnostic pitfall with sarcomas with myogenic differentiation;Antonescu;Am J Surg Pathol.,2017

5. Recurrent NTRK1 gene fusions define a novel subset of locally aggressive lipofibromatosis-like neural tumors;Agaram;Am J Surg Pathol.,2016

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on cutaneous mesenchymal tumors in the 5th edition of WHO classification of skin tumors with an emphasis on new fusion-associated neoplasms;Virchows Archiv;2024-09-12

2. Spindle Cell Lesions with Oncogenic EGFR Kinase Domain Aberrations: Expanding the Spectrum of Protein Kinase–Related Mesenchymal Tumors;Modern Pathology;2024-09

3. Drug repositioning in thyroid cancer: from point mutations to gene fusions;Frontiers in Oncology;2024-05-08

4. Remarkable response to capmatinib in a patient with intrahepatic cholangiocarcinoma harboring TFG-MET fusion;International Cancer Conference Journal;2024-03-09

5. Comprehensive clinicopathological, molecular, and methylation analysis of mesenchymal tumors with NTRK and other kinase gene aberrations;The Journal of Pathology;2024-02-09